PECARN Paediatric Head Injury
Decision rule for CT head in children with head injury. Minimises radiation exposure. Two algorithms: < 2 years and ≥ 2 years.
Score interpretation
No PECARN predictor. Validation NPV for clinically important TBI: 1176/1176 under 2; 3798/3800 aged 2 and over.
→ Discharge with head injury advice; return if worsening headache, persistent vomiting, unusual drowsiness, seizure or behaviour change.
Only intermediate-risk predictors present.
→ Observation or CT by clinician experience, multiple versus isolated findings, worsening signs, age under 3 months and parental preference.
GCS < 15, altered mental status or skull fracture signs.
→ CT head. Neurosurgery on standby if significant intracranial injury is found.
Interpretation bands for the PECARN. Apply clinical judgement and local guidance.
References
- Kuppermann N et al. Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study. Lancet. 2009;374(9696):1160-1170.
Related
Curated clinical cross-links plus same-class fallbacks.
- Cetuximab · Anti-EGFR Monoclonal Antibody — Head and Neck Cancer
- Cisplatin · Platinum Chemotherapy — Head and Neck Cancer
- Methotrexate · Chemotherapy / Immunosuppressant — Head and Neck / Granulomatosis
- Pembrolizumab (Head and Neck SCC) · PD-1 Inhibitor
- Nivolumab (Head and Neck SCC) · PD-1 Inhibitor
- Melatonin · Melatonin Receptor Agonist
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.